Medical Marijuana Inc (MJNA)

[Clariske]

Wow! They have already 45% Of Axim and I think much more. They know verywell what they are doing. That's wonderful news my friends.
The global pharmaceutical market is reported to be potentially worth nearly $1.6 trillion by 2020. AXIM Biotech intends to develop innovative pharmaceutical delivery systems and API (active pharmaceutical ingredients) for treatment of conditions such as Parkinson's disease, Alzheimer's disease, ADHD (attention deficit hyperactivity disorder), PTSD, autism, spasticity, pain, RLS (restless leg syndrome), glaucoma, IBS, IBD, Crohn's disease and more. All of these efforts are based on proprietary IP.!!!

What??? 1.6 trillion $ by 2020 . They know verywell what they are doing. The company is doing verywell, congratulations MJNA!!!!